Although there was higher retention of the tracer in the hippocampus, amygdala and entorhinal cortex of AD patients, it had a relatively high non-specific binding and it also bound tau.56 The most commonly used tracer has been 11C-PiB (Pittsburgh Compound-B). Here, MAPT is linked to Alzheimer disease.